BeOne Medicines (ONC) Total Current Liabilities (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Total Current Liabilities data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly Total Current Liabilities fell 8.68% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (down 8.68% YoY) and the FY2025 annual result came in at $1.8 billion, down 17.43% from the prior year.
• Total Current Liabilities fell to $1.8 billion in Q1 2026 per ONC's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $2.4 billion in Q3 2025 and bottomed at $917.4 million in Q4 2022.
• The 5-year median for Total Current Liabilities is $1.8 billion (2026), against an average of $1.7 billion.
• The widest annual swing landed in 2022, when Total Current Liabilities plunged 42.65%; it then surged 97.32% in 2023.
• Tracing ONC's Total Current Liabilities over 5 years: stood at $917.4 million in 2022, then surged by 97.32% to $1.8 billion in 2023, then rose by 22.36% to $2.2 billion in 2024, then decreased by 17.43% to $1.8 billion in 2025, then fell by 0.95% to $1.8 billion in 2026.
• Per Business Quant, the three latest ONC Total Current Liabilities figures stand at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $2.4 billion (Q3 2025).

Peer Comparison